FindTrial
Sign In

Gene Sequencer Clinical Trials

Gene Sequencer Clinical Trials

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100053804
Enrollment
Unknown
Registered
2021-11-29
Start date
2021-11-29
Completion date
Unknown
Last updated
2022-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-small cell lung cancer (NSCLC)

Interventions

mutant&#32
gene:&#32
EGFR/KRAS/BRAF/HER2/ALK/ROS1&#32
Gold Standard:Sanger sequencing method
Index test:Non-small&#32
cell&#32
lung&#32
cancer&#32

Sponsors

Beijing Chest Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. No age limit, no gender limit; 2. Patients with non-small cell lung cancer (NSCLC) clinically diagnosed by cytology or histology; 3. Provide samples within 3 years that meet the storage conditions; 4. The samples provided should contain no less than 30% of the tumor.

Exclusion criteria

Exclusion criteria: 1. The sample information is incomplete and the traceable sample cannot be guaranteed; 2. The researcher believes that the sample needs to be excluded.

Design outcomes

Primary

MeasureTime frame
Positive coincidence rate;—

Countries

China

Contacts

Public ContactChe Nanying

Beijing Chest Hospital

tom.liu@tongzemedical.com+86 13651394654

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026